Posts by Omair Siddiqui
AFTD Webinar: FTD Research 2025: Paving the Path Towards Effective Treatments
It has been an exciting year full of progress in FTD research with exciting updates on how we can better diagnose and treat FTD. Join AFTD’s Senior Director of Scientific…
Read MoreAFTD Webinar: Supporting FTD Care Partners with Individual Therapy
Caring for a family member with FTD can profoundly impact one’s emotional and mental well-being. Care partners are therefore often encouraged to prioritize self-care, including by seeking individual therapy. But…
Read MoreAlector Clinical Trial Results Townhall
On October 21, 2025, results from Alector Therapeutics’ Phase 3 clinical trial for Latozinemab (AL001) were announced. This intervention, designed for people with FTD caused by variants in the GRN…
Read MoreAFTD Webinar: Talking to Family About Genetic FTD Risk
When a family learns FTD is genetic, it’s important to find relatives and convey the potential risk to them, as well as raise awareness around the hope research progress offers…
Read MoreAFTD Webinar: The Lived Experience with FTD: The Road to an FTD Diagnosis
While awareness of FTD disorders is increasing, many people still face a lengthy and complicated path to receiving a diagnosis. In this webinar, presenters will share their personal journeys…
Read MoreAFTD Webinar: Speech Language Therapy — A Promising Practice in FTD Treatment and Care
When patients lose the ability to communicate effectively, doctors and other clinicians often refer them to a speech language pathologist (SLP) to help them regain their speaking skills. But for…
Read More
